Findings after ultrasound-guided fine needle ago-biopsy (FNAB) in suspected pancreatic lesions

Introduction: Pancreatic cancer is the fifth most common cause of cancer death in the Western hemisphere. It may present with few, or a short history of, symptoms, and has been called the ''silent killer'' because of the late clinical symptoms and rapid growth, and a median survival of less than 6 months. Pancreatic masses may be solid or cystic, benign or malignant. Thus differentiation of benign from malignant solid or cystic pancreatic masses is often difficult. Ultrasound-guided FNAB is a diagnostic tool characterized by simplicity, quickness of execution, high precision of sample and low cost. Aim: To asses…